Kilpest India gets approval from ICMR for TRURAPID COVID-19 Ag Test

3 Feb 2022 , 03:41 PM

Kilpest India Ltd has informed to the exchanges regarding approval of TRURAPID COVID-19 Ag Test by ICMR.

In a regulatory filing, the company said, “Finally after extensive efforts, our ‘TRURAPID COVID-19 Ag Test’ has been approved by ICMR (Indian Council of Medical Research) on February 2, 2022.

Now we will try to build this product assuming that COVID testing will continue depending on the disease progression with time.”

Further it added, “Although the prices for Rapid Antigen Test for COVID have dropped to a very low level, still we will do our efforts.”

On Thursday, Kilpest india ended at Rs455.50 per piece higher by 3.59%. The scrip touched intraday high at Rs465.20 per piece on Sensex today.